NEWARK, Del, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The Clinical Immunodiagnostics Market was estimated to be worth US$ 5.0 billion in 2023, and by 2033, it is anticipated to be worth US$ 8.4 billion. With a market share of more than 67.0%, the immunoassay kits & reagents segment now dominates the global market within the product category. From 2023 to 2033, it is projected to rise at a CAGR of almost 5.4%.
The Clinical Immunodiagnostics Market has witnessed significant growth and technological advancements in recent years, revolutionizing the field of medical diagnostics. Immunodiagnostics is a branch of clinical diagnostics that utilizes the body's immune response to detect and diagnose various diseases and conditions. It involves the analysis of specific proteins, antibodies, and antigens present in a patient's blood or other bodily fluids to identify diseases such as infectious diseases, autoimmune disorders, cancer, and allergies.
The market for clinical immunodiagnostics has been driven by several factors, including the rising prevalence of chronic and infectious diseases, an aging population, and the growing demand for personalized medicine. Moreover, the development of innovative technologies and the increasing adoption of automated systems have improved the accuracy, sensitivity, and speed of diagnostic tests, further propelling the market growth.
Get ahead of the competition with our Clinical Immunodiagnostics Market Sample Report. Access valuable insights and unlock your company's potential for success. Don't miss out on this opportunity to gain a competitive edge. Download it now! https://www.futuremarketinsights.com/reports/sample/rep-gb-17796
One of the significant advancements in immunodiagnostics has been the introduction of point-of-care (POC) testing. POC tests enable healthcare professionals to obtain rapid and real-time results, which is particularly crucial in emergency settings and remote areas with limited access to laboratory facilities. Additionally, the integration of immunodiagnostics with other advanced technologies, such as artificial intelligence and molecular diagnostics, has opened up new opportunities for early disease detection and precise treatment monitoring.
Key Takeaways from the Market Study:
- By product, immunoassay kits & reagents contributed around US$ 3.2 billion in 2022. Immunoassays often provide rapid results, allowing healthcare professionals to make timely decisions and initiate appropriate patient management. Quick turnaround times are especially important in emergency situations and critical care settings.
- Serum samples made up US$ 1.6 billion of all sample types in 2022. Serum samples are relatively stable, especially when collected and handled correctly. They can be stored for extended periods without significant degradation of the biomolecules of interest. This stability allows for easy transportation and processing of samples, making them suitable for large-scale testing and biobanking.
- By application, infectious disease contributed around US$ 989.0 Million in 2022. Infectious diseases are widespread and continue to pose a significant global health burden, thus increasing demand for immunodiagnostic practices.
- Hospitals held 26.1% of the global market share in 2022. This is due to the high accessibility of the number of patients to the hospital diagnostic facilities.
- By region, North America held a dominant share of the world in 2022, which was around 37.1%.
“The rising cases of immune diseases and increase in the adoption rate of clinical immunodiagnostics contribute to its higher demand and global expansion.” says an analyst of Future Market Insights.
Country-wise Insights: Clinical Immunodiagnostics Market:
- United States Clinical Immunodiagnostics Market:
The United States is one of the largest markets for clinical immunodiagnostics. The presence of a well-established healthcare infrastructure, high healthcare expenditure, and a large patient population contribute to the growth of this market. Additionally, the FDA's approval process for new diagnostic technologies and tests influences the market's expansion.
- Europe Clinical Immunodiagnostics Market:
European countries also have a significant market share in clinical immunodiagnostics. The region's focus on advanced healthcare technologies, favorable reimbursement policies, and increasing R&D activities contribute to market growth. Countries like Germany, France, and the United Kingdom are major players in this market.
- Asia-Pacific Clinical Immunodiagnostics Market:
The Asia-Pacific region is witnessing rapid growth in the clinical immunodiagnostics market. Factors such as a large population base, rising healthcare expenditure, increasing awareness about early disease detection, and expanding healthcare infrastructure are driving this growth. India and China are key players in this region due to their massive populations and developing healthcare systems.
- Latin America Clinical Immunodiagnostics Market:
The clinical immunodiagnostics market in Latin American countries is also expanding due to improved healthcare infrastructure, increased access to healthcare services, and rising awareness about diagnostic technologies. Brazil and Mexico are among the prominent countries contributing to market growth in this region.
- Middle East and Africa Clinical Immunodiagnostics Market:
The clinical immunodiagnostics market in the Middle East and Africa is growing steadily, driven by a rising incidence of chronic diseases and infectious diseases. Governments and healthcare organizations are investing in improving healthcare facilities and enhancing diagnostic capabilities, contributing to market expansion.
Reveal The Path To Success: Discover Actionable Insights In Our Region-Wise Report On Clinical Immunodiagnostics Market, Empowering Your Business Strategies! https://www.futuremarketinsights.com/ask-question/rep-gb-17796
Clinical Immunodiagnostics Market Competition Analysis:
The clinical immunodiagnostics market is highly competitive, with key players including QIAGEN N.V. Such companies are constantly participating in conferences, award competition with their products, and launching new products to gain a larger market share, with a focus on affordability, convenience, and effectiveness.
- In July 2023, the QIAseq Normalizer Kits have been made available by QIAGEN, providing researchers with a quick, easy, and affordable way to pool various DNA libraries for the highest-quality results from next-generation sequencing (NGS) runs.
- Surmodics, Inc.
- MESO SCALE DIAGNOSTICS, LLC.
- Abbott
- Siemens Healthineers
- PerkinElmer Inc.
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- Zoetis Inc.
- Promega Corporation
- F. Hoffmann-La Roche
- BIOMÉRIEUX SA
- Elabscience Biotechnology Inc.
- Innovative Research, Inc.
- QIAGEN N.V.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Creative Diagnostics
Awaken your strategic prowess with our Competition Deep Dive. Purchase now to unravel the mysteries of sales footprints and shape your product strategy! https://www.futuremarketinsights.com/checkout/17796
Key Market Segments Covered in the Clinical Immunodiagnostics Industry Research
By Product:
- Immunoassay Kits & Reagents
- Analyzers & Instrument
- Software
By Sample Type:
- Serum
- Plasma
- Urine
- Cerebrospinal Fluid
- Others
By Application:
- Infectious Disease
- Cardiac Disease
- Diabetes
- Autoimmune Disorders
- Inflammatory Maker
- Kidney & Liver Disease
- Oncology
- Others
By End User:
- Hospital
- Specialty Clinics
- Academic and Research Institute
- Diagnostics Laboratories
- Reference Laboratories
- Cancer Research Institutes
- Veterinary Hospitals
- Blood Banks
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Explore FMI’s related ongoing Coverage in Healthcare Market Domain:
Clinical Trial Biorepository & Archiving Solutions Market Size: The value of the Clinical Trial Biorepository & Archiving Solutions Market is projected to increase at a CAGR of around 12.1% from 2022 to 2032.
Clinical Trials Market Share: The global Clinical Trials Market is expected to enjoy a valuation of US$ 115.4 Billion by the end of the year 2023, and further expand at a CAGR of 4.41% to reach a valuation of ~US$ 177.7 Billion by the year 2033.
Rare Disease Clinical Trials Market Demand: The rare disease clinical trials market size is projected to be valued at US$ 12,566.14 million in 2023 and is expected to rise to US$ 31,715.25 million by 2033. The sales of rare disease clinical trials are expected to record a significant CAGR of 9.7% during the forecast period.
Clinical Research Organization Market Growth: According to Future Market Insights (FMI) analysis in a recent market survey, the global clinical research organization market was valued at US$ 58.0 Billion in 2022 and is expected to reach US$ 139.6 Billion by 2033.
Clinical Information System Market Opportunity: The clinical information system market is anticipated to register a CAGR of 8% during the forecast period 2022 to 2032.
Clinical Mobility Market Outlook: Clinical mobility market players now have lucrative potential thanks to technological developments and advances in the healthcare sector. Clinical mobility improves communication between patients and healthcare professionals.
Clinical Alarm Management Market Development: In 2023, the clinical alarm management market is expected to be worth US$ 3.0 billion. It is predicted to reach US$ 6.2 billion by 2033, rising at 7.5% CAGR from 2023 to 2033.
Pre-clinical Imaging System Market Strategies: The field of imaging science is expanding and has an impact on several biological research fields, including oncology, neurology, cardiology, immunology, and infectious illnesses.
EClinical Solutions and Software Market Trends: The global market is expected to enjoy a valuation of US$ 9.3 Billion by the end of the year 2023, and further expand at a CAGR of 12.1% to reach a valuation of ~US$ 29.1 Billion by the year 2033.
Clinical Chemistry Enzymes Market Analysis: According to Future Market Insights research, during the projected period, the Global Clinical Chemistry Enzymes market is expected to grow at a CAGR of 5.9%. The market value is projected to increase from US$ 3.2 Billion in 2023 to US$ 5.7 Billion by 2033.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
